💊 unlocking synthetic lethality: targeting parp inhibition in brca1 and brca2 mutant cancers 🛑
Published 4 years ago • 5K plays • Length 9:20Download video MP4
Download video MP3
Similar videos
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
5:19
mechanisms of parp inhibition: a mode of targeted cancer treatment
-
0:54
parp inhibitors advance beyond treatment of brca1/2-mutant gynecologic cancers
-
3:56
parp inhibitors: activity in brca1 versus brca2 altered mcrpc
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
1:58
discussing targeted treatment with parp inhibitors for brca-mutant patients across tumor types
-
17:17
2019 stat115 lect20.4 synthetic lethality
-
22:27
parp and dna repair defects (brca mutations) - karen e. knudsen
-
6:21
parp inhibition in brca1/2 or hrd- ovarian cancer
-
2:38
parp inhibitors
-
20:00
contribution of synthetic lethality to cancer risk... - nishanth nair - gencompbio - ismb/eccb 2019
-
0:27
parp inhibitors #short
-
3:17
mrtx9768: a synthetic lethal-based inhibitor designed to bind the prmt5•mta complex and target m...
-
3:12
parp-inhibitors: a new generation of cancer drugs
-
3:31
distinguishing between parp inhibitors in breast cancer
-
5:06
ovarian cancer: the role of parp inhibitors and beyond
-
1:47
an overview of the ma17r trial in breast cancer
-
0:58
use of parp1-selective and atr inhibitors to target ddr signalling pathway